Testicular Cancer Survivorship: Looking Back to Move Forward
- PMID: 34591594
- PMCID: PMC8577670
- DOI: 10.1200/JCO.21.01984
Testicular Cancer Survivorship: Looking Back to Move Forward
Conflict of interest statement
Comment on
-
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort.J Clin Oncol. 2021 Nov 10;39(32):3561-3573. doi: 10.1200/JCO.21.00637. Epub 2021 Aug 13. J Clin Oncol. 2021. PMID: 34388002
References
-
- Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016 CA Cancer J Clin 66271–2892016 - PubMed
-
- Einhorn LH, Donohue J.Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer Ann Intern Med 87293–2981977 - PubMed
-
- Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 data Lancet Oncol 8784–7962007 - PubMed
-
- Fung C, Dinh PC, Fossa SD, et al. Testicular cancer survivorship J Natl Compr Canc Netw 171557–15682019 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical